Bai S, Wang J, Yang K, Zhou C, Xu Y, Song J, Gu Y, Chen Z, Wang M, Shoen C, Andrade B, Cynamon M, Zhou K, Wang H, Cai Q, Oldfield E, Zimmerman SC, Bai Y, Feng X (2021) A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action. Sci Adv. https://doi.org/10.1126/sciadv.abc9917
Article PubMed PubMed Central Google Scholar
Cho BC, Obermannova R, Bearz A, McKeage M, Kim DW, Batra U, Borra G, Orlov S, Kim SW, Geater SL, Postmus PE, Laurie SA, Park K, Yang CT, Ardizzoni A, Bettini AC, de Castro G, Jr., Kiertsman F, Chen Z, Lau YY, Viraswami-Appanna K, Passos VQ, Dziadziuszko R (2019) Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-positive NSCLC: primary efficacy results from the ASCEND-8 study. J Thorac 14(7):1255–1265. https://doi.org/10.1016/j.jtho.2019.03.002
Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, Clair G, Adkins JN, Cheung AL, Lewis K (2016) Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol 1:16051. https://doi.org/10.1038/nmicrobiol.2016.51
Article CAS PubMed PubMed Central Google Scholar
Craft KM, Nguyen JM, Berg LJ, Townsend SD (2019) Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype. Medchemcomm 10(8):1231–1241. https://doi.org/10.1039/c9md00044e
Article CAS PubMed PubMed Central Google Scholar
Crunkhorn S (2017) Polypharmacology: tepurposing ceritinib. Nat Rev Drug Discov 16(12):828. https://doi.org/10.1038/nrd.2017.233
Article CAS PubMed Google Scholar
David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23(3):616–687. https://doi.org/10.1128/cmr.00081-09
Article CAS PubMed PubMed Central Google Scholar
de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PHS, Kamp N, El Ghalbzouri A, Lohner K, Zaat SAJ, Drijfhout JW, Nibbering PH (2018) The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aan4044
De Oliveira DMP, Bohlmann L, Conroy T, Jen FE, Everest-Dass A, Hansford KA, Bolisetti R, El-Deeb IM, Forde BM, Phan MD, Lacey JA, Tan A, Rivera-Hernandez T, Brouwer S, Keller N, Kidd TJ, Cork AJ, Bauer MJ, Cook GM, Davies MR, Beatson SA, Paterson DL, McEwan AG, Li J, Schembri MA, Blaskovich MAT, Jennings MP, McDevitt CA, von Itzstein M, Walker MJ (2020) Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Sci Transl Med. https://doi.org/10.1126/scitranslmed.abb3791
Article PubMed PubMed Central Google Scholar
Dos Santos SBF, Pereira SA, Rodrigues FAM, da Silva ACC, de Almeida RR, Sousa ACC, Fechine L, Denardin JC, Araneda F, Sá L, da Silva CR, Nobre Júnior HV, Ricardo N (2020) Antibacterial activity of fluoxetine-loaded starch nanocapsules. Int J Biol Macromol 164:2813–2817. https://doi.org/10.1016/j.ijbiomac.2020.08.184
Article CAS PubMed Google Scholar
Ezraty B, Gennaris A, Barras F, Collet JF (2017) Oxidative stress, protein damage and repair in bacteria. Nat Rev Microbiol 15(7):385–396. https://doi.org/10.1038/nrmicro.2017.26
Article CAS PubMed Google Scholar
Fukazawa H, Fukuyama M, Miyazaki Y (2019) Expression of active Staphylococcus aureus tyrosine kinases in a human cell line. Biol Pharm Bull 42(3):411–416. https://doi.org/10.1248/bpb.b18-00722
Article CAS PubMed Google Scholar
García-Fernández E, Koch G, Wagner RM, Fekete A, Stengel ST, Schneider J, Mielich-Süss B, Geibel S, Markert SM, Stigloher C, Lopez D (2017) Membrane microdomain disassembly inhibits MRSA antibiotic resistance. Cell 171(6):1354-1367.e20. https://doi.org/10.1016/j.cell.2017.10.012
Article CAS PubMed PubMed Central Google Scholar
Gaurav A, Gupta V, Shrivastava SK, Pathania R (2021) Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli. Commun Biol 4(1):542. https://doi.org/10.1038/s42003-021-02074-5
Article CAS PubMed PubMed Central Google Scholar
Gruszczyk J, Olivares-Illana V, Nourikyan J, Fleurie A, Béchet E, Gueguen-Chaignon V, Freton C, Aumont-Nicaise M, Moréra S, Grangeasse C, Nessler S (2013) Comparative analysis of the Tyr-kinases CapB1 and CapB2 fused to their cognate modulators CapA1 and CapA2 from Staphylococcus aureus. PLoS ONE 8(10):e75958. https://doi.org/10.1371/journal.pone.0075958
Article CAS PubMed PubMed Central Google Scholar
Guisier F, Piton N, Bellefleur M, Delberghe N, Avenel G, Angot E, Vittecoq O, Ould-Slimane M, Morisse-Pradier H, Salaun M, Thiberville L (2020) Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case report. BMC Cancer 20(1):14. https://doi.org/10.1186/s12885-019-6486-3
Article CAS PubMed PubMed Central Google Scholar
Gunther G, Malacrida L, Jameson DM, Gratton E, Sánchez SA (2021) LAURDAN since weber: the quest for visualizing membrane heterogeneity. Acc Chem Res 54(4):976–987. https://doi.org/10.1021/acs.accounts.0c00687
Article CAS PubMed PubMed Central Google Scholar
Guo XJ, Cao B, Wang CY, Lu SY, Hu XL (2020) In vivo photothermal inhibition of methicillin-resistant Staphylococcus aureus infection by in situ templated formulation of pathogen-targeting phototheranostics. Nanoscale 12(14):7651–7659. https://doi.org/10.1039/d0nr00181c
Article CAS PubMed Google Scholar
Hirota T, Muraki S, Ieiri I (2019) Clinical pharmacokinetics of anaplastic lymphoma kinase inhibitors in non-small-cell lung cancer. Clin Pharmacokinet 58(4):403–420. https://doi.org/10.1007/s40262-018-0689-7
Article CAS PubMed Google Scholar
Hodille E, Rose W, Diep BA, Goutelle S, Lina G, Dumitrescu O (2017) The role of antibiotics in modulating virulence in Staphylococcus aureus. Clin Microbiol Rev 30(4):887–917. https://doi.org/10.1128/cmr.00120-16
Article CAS PubMed PubMed Central Google Scholar
Hyun S, Choi Y, Jo D, Choo S, Park TW, Park SJ, Kim S, Lee S, Park S, Jin SM, Cheon DH, Yoo W, Arya R, Chong YP, Kim KK, Kim YS, Lee Y, Yu J (2020) Proline hinged amphipathic α-helical peptide sensitizes gram-negative bacteria to various gram-positive antibiotics. J Med Chem 63(23):14937–14950. https://doi.org/10.1021/acs.jmedchem.0c01506
Article CAS PubMed Google Scholar
Jia Y, Zheng Z, Xue M, Zhang S, Hu F, Li Y, Yang Y, Zou M, Li S, Wang L, Guan M, Xue Y (2019) Extracellular vesicles from albumin-induced tubular epithelial cells promote the M1 macrophage phenotype by targeting klotho. Mol Ther 27(8):1452–1466. https://doi.org/10.1016/j.ymthe.2019.05.019
Article CAS PubMed PubMed Central Google Scholar
Khan F, Pham DTN, Tabassum N, Oloketuyi SF, Kim YM (2020) Treatment strategies targeting persister cell formation in bacterial pathogens. Crit Rev Microbiol 46(6):665–688. https://doi.org/10.1080/1040841x.2020.1822278
Article CAS PubMed Google Scholar
Khozin S, Blumenthal GM, Zhang L, Tang S, Brower M, Fox E, Helms W, Leong R, Song P, Pan Y, Liu Q, Zhao P, Zhao H, Lu D, Tang Z, Al Hakim A, Boyd K, Keegan P, Justice R, Pazdur R (2015) FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. Clin Cancer Res 21(11):2436–2439. https://doi.org/10.1158/1078-0432.Ccr-14-3157
Article CAS PubMed Google Scholar
Kim W, Zou G, Hari TPA, Wilt IK, Zhu W, Galle N, Faizi HA, Hendricks GL, Tori K, Pan W, Huang X, Steele AD, Csatary EE, Dekarske MM, Rosen JL, Ribeiro NQ, Lee K, Port J, Fuchs BB, Vlahovska PM, Wuest WM, Gao H, Ausubel FM, Mylonakis E (2019) A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 116(33):16529–16534. https://doi.org/10.1073/pnas.1904700116
Article CAS PubMed PubMed Central Google Scholar
Kosgodage US, Matewele P, Mastroianni G, Kraev I, Brotherton D, Awamaria B, Nicholas AP, Lange S, Inal JM (2019) Peptidylarginine deiminase inhibitors reduce bacterial membrane vesicle release and sensitize bacteria to antibiotic treatment. Front Cell Infect Microbiol 9:227. https://doi.org/10.3389/fcimb.2019.00227
Article CAS PubMed PubMed Central Google Scholar
Lakhundi S, Zhang K (2018) Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. https://doi.org/10.1128/cmr.00020-18
Article PubMed PubMed Central Google Scholar
Le P, Kunold E, Macsics R, Rox K, Jennings MC, Ugur I, Reinecke M, Chaves-Moreno D, Hackl MW, Fetzer C, Mandl FAM, Lehmann J, Korotkov VS, Hacker SM, Kuster B, Antes I, Pieper DH, Rohde M, Wuest WM, Medina E, Sieber SA (2020) Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms. Nat Chem 12(2):145–158. https://doi.org/10.1038/s41557-019-0378-7
Article CAS PubMed Google Scholar
Li S, She P, Zhou L, Zeng X, Xu L, Liu Y, Chen L, Wu Y (2020) High-throughput identification of antibacterials against Pseudomonas aeruginosa. Front Microbiol 11:591426. https://doi.org/10.3389/fmicb.2020.591426
Article PubMed PubMed Central Google Scholar
Liu P, Yang Y, Tang Y, Yang T, Sang Z, Liu Z, Zhang T, Luo Y (2019) Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents. Eur J Med Chem 163:169–182. https://doi.org/10.1016/j.ejmech.2018.11.054
Article CAS PubMed Google Scholar
Liu Y, She P, Xu L, Chen L, Li Y, Liu S, Li Z, Hussain Z, Wu Y (2021) Antimicrobial, antibiofilm, and anti-persister activities of penfluridol against Staphylococcus aureus. Front Microbiol 12:727692. https://doi.org/10.3389/fmicb.2021.727692
留言 (0)